(VIANEWS) – CATANA GROUP (CATG.PA), SELVAAG BOLIG (SBO.OL), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CATANA GROUP (CATG.PA)
39.4% sales growth and 30.39% return on equity
SA Catana Group manufactures and sells pleasure boats, sails, and motors in France and internationally. It also offers boat work, garage rentals, guarding, and berth services. The company markets its products under the CATANA, BALI, and CATSPACE brands. SA Catana Group was founded in 2001 and is headquartered in Canet-en-Roussillon, France.
Earnings Per Share
As for profitability, CATANA GROUP has a trailing twelve months EPS of €0.57.
PE Ratio
CATANA GROUP has a trailing twelve months price to earnings ratio of 10.39. Meaning, the purchaser of the share is investing €10.39 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.39%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 33.8%, now sitting on 172.53M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 1, 2023, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 2.5%.
More news about CATANA GROUP.
2. SELVAAG BOLIG (SBO.OL)
31.3% sales growth and 8.14% return on equity
Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.
Earnings Per Share
As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr1.94.
PE Ratio
SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 16.01. Meaning, the purchaser of the share is investing kr16.01 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.14%.
More news about SELVAAG BOLIG.
3. MONTEA (MONT.BR)
25.8% sales growth and 5.79% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specialises in logistical property in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 30/09/2023 the property portfolio represented a total surface of 1,921,172 m² spread across 94 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €3.82.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 22.25. Meaning, the purchaser of the share is investing €22.25 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.79%.
More news about MONTEA.
4. SONAE (SON.LS)
10.5% sales growth and 9.35% return on equity
Sonae, SGPS, S.A. engages in retail, financial services, technology, shopping center, and telecommunications businesses. The company operates hypermarkets under the Continente brand; convenience supermarkets under the Continente Modelo and Continente Bom Dia brands; franchised supermarkets under the Meu Super brand; cafeteria under the Bagga brand; healthy food supermarkets and restaurants under the Go Natural brand; book shops and stationery under the Make Notes and Note! brands; health, well-being, and eye care centers under the Well´s brand; and dental and aesthetic medicine clinics under the Dr. Well's brand, as well as provides dog and cat products and services under the ZU brand. It also offers clothing, footwear, and accessories under the MO brand; baby and children clothing, footwear, and accessories, as well as childcare products under the Zippy and Losan brands; and jeans, clothing, and accessories under the Salsa brand. In addition, the company sells consumer electronics and entertainment products under the Worten brand; and mobile telecommunications products under the Worten Mobile brand, as well as develops real estate properties. Further, it offers payments, cards, personal loans, and insurance under the Universo brand; financing online purchases under the Universo Flex brand; and meal vouchers, gifting, and rewarding under the Da cards brand, as well as operates sports retail stores under JD, Sprinter, and Size? brand names. Additionally, the company provides telecommunication services to residential, personal, corporate, and wholesale markets; and investment management activities. It operates in Portugal, Spain, France, the United Kingdom, Germany, Italy, Romania, Brazil, Mexico, the Netherlands, and internationally. Sonae, SGPS, S.A. was founded in 1959 and is headquartered in Maia, Portugal. Sonae, SGPS, S.A. operates as a subsidiary of Efanor Investimentos SGPS, SA.
Earnings Per Share
As for profitability, SONAE has a trailing twelve months EPS of €0.11.
PE Ratio
SONAE has a trailing twelve months price to earnings ratio of 8.27. Meaning, the purchaser of the share is investing €8.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.35%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SONAE’s EBITDA is 25.98.
More news about SONAE.
5. ING GROEP N.V. (INGA.AS)
7% sales growth and 29.72% return on equity
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.62.
PE Ratio
ING GROEP N.V. has a trailing twelve months price to earnings ratio of 8.41. Meaning, the purchaser of the share is investing €8.41 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.72%.
Volume
Today’s last reported volume for ING GROEP N.V. is 6854210 which is 36.76% below its average volume of 10839300.
Revenue Growth
Year-on-year quarterly revenue growth grew by 39.7%, now sitting on 34.06B for the twelve trailing months.
More news about ING GROEP N.V..
6. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 22.5. Meaning, the purchaser of the share is investing kr22.5 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr22.50 at 11:20 EST, way under its 52-week high of kr25.10 and way above its 52-week low of kr15.10.
Volume
Today’s last reported volume for VISTIN PHARMA is 8031 which is 60.71% below its average volume of 20441.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 438.54M for the twelve trailing months.
More news about VISTIN PHARMA.
